NCT02566252View on ClinicalTrials.gov

Effect of Pre-Treatment With Cromolyn or Albuterol on Response to PUL-042 Inhalation Solution (PUL-042)

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

January 31, 2016

Study Completion Date

March 31, 2016

Conditions
Healthy
Interventions
DRUG

PUL-042 Inhalation Solution

PUL-042

DRUG

Cromolyn Sodium

Pre-treatment

DRUG

Albuterol sulfate

Pre-treatment

Trial Locations (1)

90630

WCCT Global, Cypress

Sponsors

Collaborators (1)

WCCT Global
All Listed Sponsors
collaborator

WCCT Global

INDUSTRY

lead

Pulmotect, Inc.

INDUSTRY

NCT02566252 - Effect of Pre-Treatment With Cromolyn or Albuterol on Response to PUL-042 Inhalation Solution (PUL-042) | Biotech Hunter | Biotech Hunter